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NIR IS A NUCLEOLAR RNA-BINDING PROTEIN THAT IS INVOLVED IN  
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Abstract – A novel inhibitor of histone acetyltransferase repressor (NIR) is a histone acetylation inhibitor that associates 
with p53, p63 and histone complexes. Staining with anti-NIR antibodies revealed that the protein is localized at the nucleo-
lus. The nucleolar localization of NIR was lost upon RNase treatment, whereas its localization was unaffected by treatment 
with DNase. These results indicate that NIR directly or indirectly binds RNA in the nucleolus. The expression of NIR pro-
tein was higher in cancer cell lines than in non-cancer cell lines. The proliferation rate of human embryonic kidney 293T 
cells was higher following the ectopic expression of NIR than following the ectopic expression of green fluorescent protein 
(GFP). In summary, NIR is an RNA-associated protein that is involved in the cell proliferation regulation.
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INTRODUCTION
Initially, the nucleolus was simply thought to be the 
site  of  ribosomal  RNA  (rRNA)  transcription  and 
processing that is required to synthesize the ribos-
ome complex. However, several studies suggest that 
the nucleolus also plays pivotal roles in the process-
ing  of  telomere  RNA,  transfer  RNA  (tRNA),  U6 
small nuclear RNA and signal recognition particle 
(SRP) RNA (Pederson, 1998). Furthermore, the nu-
cleolus is involved in gene expression, cell cycle regu-
lation and DNA damage repair (Emmott and Hiscox, 
2009). p53 and its regulator, MDM2, are important 
factors in these processes (Klibanov et al., 2001). Pro-
tein 53 is a transcription factor for several cell cycle 
arrest genes, such as p21, and several pro-apoptotic 
genes, such as BAX, PIG3, and NOXA (Riley et al., 
2008). The stability of the p53 protein is regulated by 
ubiquitination that is conducted by the p53-specific 
ubiquitin ligase, MDM2. The nucleolus is the place 
where MDM2 is sequestered by binding to ARF af-
ter cellular stress, such as ultraviolet irradiation and 
DNA damage, which thereby leads to p53 stabiliza-
tion (Weber et al., 1999).
The novel inhibitor of histone acetyltransferase 
repressor (NIR) was isolated as a binding partner 
of p53 (Heyne et al., 2010, Hublitz et al., 2005). It 
also binds core histones and thereby prevents the 
acetylation of histones by histone acetyltransferases 
in  p53-dependent  reporter  genes  and  endogenous 
p53 target genes (Heyne et al., 2010, Hublitz et al., 
2005). Depletion of NIR using short interfering RNA 
increases  p53-dependent  apoptosis  (Hublitz  et  al., 
2005). NIR promotes phosphorylation of the DNA-
binding domain of p53 by Aurora B kinase, thereby 
inhibiting transcription of p53 target genes (Wu et 
al., 2011). NIR also binds p63, a major regulator of 
stratified  epithelial  morphogenesis,  and  inhibits 
p63-dependent transactivation of p21 (Heyne et al., 930 MIN KOOK KANG ET AL.
2010). NIR has recently been reported to play a role 
in the rRNA processing of the 40S and 60S ribosomal 
subunits (Wu et al., 2012).
To understand better the roles of NIR in cell cy-
cle regulation, we studied the cellular localization of 
NIR and examined the rate of cell proliferation after 
overexpression of NIR. NIR is localized in the nucle-
olus by binding to RNA or an RNA-binding protein 
and is involved in cell proliferation.
MATERIALS AND METHODS
Construction of NIR expression plasmids
Human NIR cDNA was subcloned between the KpnI 
and NotI sites of pcDNA3.1, and was tagged with a 
FLAG epitope at the carboxyl terminus. The result-
ing plasmid was digested with KpnI and EcoRV and 
the fragment was subcloned into the pEGFP-C1 vec-
tor that had been digested with KpnI and SmaI to 
generate amino terminally GFP-tagged NIR.
Production of anti-NIR antibodies
A  fragment  of  mouse  NIR  cDNA  (amino  acids 
500–750) was digested with SacI and XhoI and in-
serted into the pQE31 vector to allow expression of 
His-tagged NIR. The protein was expressed, purified 
and then injected into rabbits to raise a polyclonal 
antibody against mouse NIR (MoAb). A polyclonal 
antibody against human NIR (HuAb) was raised in 
rabbits using a 17 amino acid peptide of the carboxyl 
terminus of human NIR (AQGPEDELEDLQLSEDD) 
(Peptron, Deajeon, Korea). Both antibodies were pu-
rified and used for Western blotting and immunocy-
tochemistry. 
Cell culture and cell transfection
Human embryonic kidney (HEK) 293T, HeLa and 
NIH3T3 cells were cultured in Dulbecco modified 
Eagle’s medium (Hyclone, Logan, UT), supplement-
ed with 10% fetal bovine serum (FBS, Life technolo-
gies, Carlsbad, CA), 100 IU/ml penicillin and 100 
µg/ml streptomycin at 37°C in 5% CO2. For ectopic 
expression of NIR constructs, cells were grown to 
70% confluency on 60 mm or 100 mm dishes and 
were then transfected using the JetPEI transfection 
reagent (Polyplus Transfection Inc, NY), according 
to the manufacturer’s protocol. All of the cell lines, 
including non-cancer cell lines (WI-38, lung fibrob-
last; MRC5, lung fibroblast; Hel 299, lung embryo 
fibroblast) and cancer cell lines (A427, lung carci-
noma; A549, lung carcinoma; NCI-H23, non-small 
cell lung adenocarcinoma), were purchased from the 
Korean Cell Line Bank (Seoul, Korea). To check the 
cell growth rate after NIR transfection, the number 
of  cells  was  counted  with  a  hemocytometer  after 
trypsinization. To synchronize HeLa cell at early S 
phase, aphidicolin, a reversible inhibitor of eukaryo-
tic nuclear DNA replication, was used. 8×105 HeLa 
cells were plated in 60-mm dishes, and aphidicolin 
was added to a final concentration of 5nM for 12 h. 
The synchronized cells were collected every 3 h after 
release from early S block by removing the reagent.
Western blot analysis
Cells were cultured for 24 h after transfection and 
then  washed  with  cold  phosphate  buffered  saline 
(PBS). For cell fractionation, whole-cell extracts were 
prepared in RIPA buffer (25 mM Tris-HCl pH 7.6, 
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 
0.1% sodium dodecyl sulphate (SDS), 1 mM PMSF, 
50 mM NaF, 4 µg/ml aprotinin, 0.7 µg/ml pepstatin 
and 0.5 µg/ml leupeptin), which enables protein ex-
traction from cytoplasmic, membrane and nuclear 
compartments. The sample was rotated at 4°C for 
15 min and centrifuged at 13,000 rpm for 20 min. 
The  supernatant  containing  soluble  proteins  was 
collected (soluble fraction, S). The pellet was resus-
pended in the same volume of SDS-polyacrylamide 
gel electrophoresis (PAGE) loading buffer (62.5 mM 
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.1 M DTT, 
0.005% bromophenol blue) and was boiled to extract 
proteins  (insoluble  fraction,  I).  The  same  amount 
of soluble or insoluble cell lysates was subjected to 
SDS-PAGE and Western blotting. NIR was detected 
by incubating the blot for 2 h with purified anti-NIR 
antibodies (1:1000 dilution), and then with horse-
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son  ImmunoResearch,  West  Grove,  PA).  Proteins 
were visualized with enhanced chemiluminescence 
(GE Healthcare Bio-Sciences). 
Immunocytochemistry
To  examine  the  cellular  localization  of  NIR,  cells 
were grown on poly-L lysine-coated coverslips. After 
fixation with 4% formaldehyde prepared in PBS for 
1 hr, cells were permeabilized with blocking solution 
(PBS containing 1% BSA and 0.3% Triton X-100) for 
20 min on ice. Cells were incubated with anti-NIR 
antibodies prepared in blocking solution for 2 h and 
were then incubated with an FITC- or Cy3-conju-
gated  anti-rabbit  secondary  antibody  prepared  in 
blocking solution for 20 min. DNA was stained with 
Hoechst  or  DAPI  solutions  (Invitrogen,  Carlsbad, 
California). Mounted coverslips were observed with 
a Nikon Eclipse 2000 microscope (Melville, NY). To 
determine the effects of DNase and RNase on the lo-
calization of NIR, we modified a previously reported 
protocol  (Galcheva-Gargova  et  al.,  1998).  Briefly, 
HeLa cells grown on coverslips were permeabilized 
with 0.1% Triton X-100 for 3 min on ice. Cells were 
washed three times, and were then incubated for 60 
min at 37°C with PBS containing 0.1 mg/ml RNase 
A or PBS containing 0.1 mg/ml DNase I and 5 mM 
MgCl2. Cells were incubated with PBS as a negative 
control.
RESULTS
Characterization of anti-NIR antibodies
In order to determine the role of the NIR in the cell 
cycle, we raised polyclonal antibodies against a frag-
ment of mouse NIR (amino acids 500-750) and a 
17-amino-acid peptide from the carboxyl terminus 
of human NIR. Human NIR consists of 749 amino 
acids (750 amino acids for mouse), therefore, the 
calculated molecular weight of NIR protein is about 
85kD. The antibody which was generated with hu-
man NIR peptide recognized endogenous and over-
expressed NIR protein by Western blotting around 
95kD (Fig. 1A). Endogenous and exogenous NIR 
protein in the insoluble fraction migrated slower than 
that in the soluble fraction (Fig. 1A). The MoAb also 
generated an intense band corresponding to NIR in 
various adult mouse tissues, including the brain, kid-
ney, lung, thymus, heart and liver (Fig. 1B). These 
results  indicate  that  the  generated  antibodies  can 
specifically recognize NIR protein and that NIR pro-
tein is widely expressed in various murine tissues. 
NIR accumulates in the nucleolus
The cellular localization of NIR is controversial. NIR 
localizes in the nucleoplasm in doxorubicin-treated 
BHK cells (Hublitz et al., 2005) and in U2OS cells 
overexpressing Aurora B kinase (Wu et al., 2011). In 
contrast, NIR is reported to localize in the nucleolus 
in U2OS cells and HeLa cells (Wu et al., 2012). NIR 
is found in the nucleolus and nucleoplasm in H1299 
cells transfected with TAp63γ (Heyne et al., 2010). 
Therefore, immunocytochemistry with the two anti-
NIR antibodies was performed to study the cellular 
localization of endogenous NIR. Fluorescence was 
detected predominantly in the nucleolus in almost all 
cells, indicating that NIR is localized in the nucleo-
lus (Fig. 2). Both antibodies had the same fluores-
cence pattern in human HeLa cells (Fig 2B.g) and 
mouse NIH3T3 cells (Fig. 2C.j). Fluorescence was 
not detected when cells were treated with the sec-
ondary antibody alone (Fig 2A.c), indicating that the 
fluorescence generated was due to the anti-NIR anti-
bodies. To confirm that NIR localizes in the nucleo-
lus, we overexpressed GFP-NIR in HeLa cells. GFP 
fluorescence was mainly detected in the nucleolus 
and a faint signal was detected in the nucleoplasm 
(Fig 2D.n). These results indicate that endogenous 
NIR  is  predominantly  located  in  the  nucleolus  in 
resting cells and that overexpression of the protein 
could lead to translocation of NIR to nucleoplasm.
RNA is required for the nucleolar localization of NIR
The  nucleolus  contains  abundant  ribosomal  DNA 
and is the site at which various types of RNA are 
processed, including rRNA, telomere RNA, tRNA, 
U6 small nuclear RNA and SRP RNA. Consequently, 
we examined whether the nucleolar localization of 
NIR requires DNA and/or RNA by treating cells with 932 MIN KOOK KANG ET AL.
DNase or RNase, respectively. NIR was no longer lo-
calized at the nucleolus following RNase treatment, 
whereas  its  localization  was  unaff  ected  by  DNase 
treatment (Fig 3). Staining with Hoechst solution was 
not detected when cells were treated with DNase, in-
dicating that the treatment eff  ectively cleaved DNA. 
Th   ese results indicate that the nucleolar localization 
of NIR is dependent on its association with RNA or 
an RNA-bound protein.
NIR expression is modulated throughout the cell cycle
NIR interacts with p53 and p63, which regulate cell 
cycle arrest (Heyne et al., 2010, Hublitz et al., 2005). 
Consequently, we investigated whether NIR expres-
sion changes throughout the cell cycle in cell cycle 
arrested and released HeLa cells. As shown in the 
Fig. 4A, NIR expression decreased as cell enters M 
phase though G2. Since NIR expression appears to 
depend on cell cycle progression, NIR protein ex-
pression was examined in several non-cancer cell 
lines (WI-38, MRC5, Hel 299) and several cancer 
cell lines (A427, A549, NCI-H23). Generally, NIR 
expression was higher in the cancer cell lines than 
in the non-cancer cell lines (Fig. 4B). The level of 
NIR was similar in the insoluble fraction of each of 
the cell lines, whereas NIR expression was markedly 
higher in the soluble fractions of the cancer cell lines 
than in those of the non-cancer cell lines. β-tubulin 
was used as a loading control. These results suggest 
that the expression of NIR is modulated throughout 
the cell cycle.
Fig. 1. NIR is widely expressed in various murine tissues. (A) Flag-NIR transfected (+) or non-transfected (-) HEK293 cell lysates 
were detected with Flag antibody (left   panel). Th   e same blot was stripped and re-probed with NIR HuAb (right panel). HuAb detected 
endogenous NIR (arrows) and FLAG-tagged NIR (arrowheads). FLAG-tagged NIR migrated slower than endogenous NIR due to 
the additional 15 amino acid residues of the tag. NIR in the soluble fraction (S) migrated faster than NIR in the insoluble fraction (I). 
(B) Th   e expression of NIR in various murine tissues was examined by Western blotting. Lysates of various tissues were prepared and 
fractionated on an 8% SDS-PAGE gel (100 µg per lane). Th   e gel was transferred to a PVDF membrane and probed with MoAb. Th   e 
positions of protein standards are indicated on the left   (in kDa). B, brain; H, heart; K, kidney; L, liver; U, lung; Y, lymph node; O, ovary; 
S, spleen; T, thymus. NIR IS A NUCLEOLAR RNA-BINDING PROTEIN THAT IS INVOLVED IN CELL PROLIFERATION 933
Overexpression of  NIR enhances cell proliferation
NIR expression varied throughout the cell cycle and 
NIR may be involved in cell cycle arrest via its as-
sociation with p53 and p63. Therefore, the effect of 
NIR on cell proliferation was investigated by overex-
pressing HA- or GFP-tagged NIR in HeLa cells. To 
exclude the effect of ectopic protein expression on 
the cell growth, GFP was used as a negative control. 
The number of HeLa cells was 2-fold higher 4 days 
after transfection of HA-NIR or GFP-NIR than af-
ter transfection of GFP (Fig. 5). These results suggest 
that NIR regulates cell proliferation.
DISCUSSION
Many lines of evidence indicate that the nucleolus 
is not only the site of ribosome biogenesis but is 
also responsible for the regulation of many cellular 
processes, such as the cell cycle, apoptosis and stress 
sensing (Montanaro et al., 2008, Sirri et al., 2008). 
Proteomic analyses suggest there are more than 270 
proteins in the nucleolus (Andersen et al., 2002). 
Among them, B23 (also known as nucleophosmin) 
and C23 (also known as nucleolin) have been well 
studied. These proteins interact with nucleic acids 
and are involved in ribosome biogenesis (Cong et al., 
2012, Okuwaki et al., 2002). However, several recent 
Fig. 2. NIR accumulates in the nucleolus. (A) Cells were treated with a FITC-conjugated anti-rabbit antibody alone to confirm that 
the signals in (g) and (j) are due to NIR specific Abs (a–d). The asterisked dark structures in the nucleus are the nucleoli (a, e). (scale 
bar, 10 µm) (B) Endogenous NIR was detected using HuAb and a FITC-conjugated anti-rabbit antibody (e–h). HeLa cells grown on 
coverslips were stained with HuAb and a FITC-conjugated anti-rabbit antibody. The localization of endogenous NIR in HeLa cells is 
predominantly nucleolar. (C) MoAb specifically labels the NIR in the nucleolus of NIH3T3 cells same as HuAb in (B). (D) GFP-NIR 
was primarily localized in the nucleolus, similar to endogenous NIR. GFP-NIR was also detected in the nucleoplasm. Mitochondria 
were stained with Mitotracker® for 30 min prior to fixation to distinguish between the cytoplasm and nuclei (l). Nuclei were stained with 
Hoechst (b, f, m).934 MIN KOOK KANG ET AL.
Fig. 3. RNA is required for the nucleolar localization of NIR. NIH3T3 cells were treated with DNase or RNase as described in the 
materials and methods. Aft  er fi  xation, NIR antibody (MoAb) and a FITC-conjugated anti-rabbit antibody. Cells were incubated with 
PBS as a negative control (not treated, NT). Nuclear DNA was stained with DAPI.
Fig. 4. NIR expression is modulated throughout the cell cycle. (A) NIR expression decreased during M phase. HeLa cells were har-
vested at various time-points aft  er being released from cell cycle arrest which was induced by aphidicolin treatment. Cell lysates were 
resolved by SDS-PAGE, and Western blotting was performed with MoAb. Cyclin A which is mainly expressed in the G2 phase was 
monitored as a cell cycle indicator. Th   e positions of protein standard markers are indicated on the left   (in kDa). (B) NIR expression was 
monitored in three cancer cell lines (C) and three non-cancer cell lines (N). Generally, NIR expression in the soluble fraction was higher 
in cancer cell lines than in non-cancer cell lines. β-tubulin was used as a loading control.NIR IS A NUCLEOLAR RNA-BINDING PROTEIN THAT IS INVOLVED IN CELL PROLIFERATION 935
reports suggest that B23 and C23 also contribute to 
the regulation of the cell cycle, cell proliferation, and 
centrosome  duplication,  since  genomic  instability 
and defective centrosome duplication are observed 
when these proteins are inactivated (Okuda et al., 
2000, Reboutier et al., 2012, Tarapore et al., 2002, 
Ugrinova et al., 2007). Another nucleolar protein, 
nucleolar protein p120 (NOL1), binds rRNA and its 
expression increases during proliferation. Overex-
pression of NOL1 leads to the malignant transfor-
mation of NIH3T3 cells and NOL1 expression dra-
matically increases during the G1/S transition, which 
suggests that NOL1 regulates the cell cycle (Fonagy 
et al., 1993). Th   ese data indicate that many proteins 
Fig. 5. Overexpression of NIR enhances cell proliferation. (A) HEK293 cells (1x105) cultured on 60 mm dishes in media containing 
10% FBS were transfected with GFP, HA-NIR or GFP-NIR. Cells were counted 1, 2, 3, and 4 days aft  er transfection to determine the level 
of cell proliferation. Th   e number of cells was signifi  cantly higher 4 days aft  er transfection of HA-NIR or GFP-NIR than aft  er transfection 
of GFP. (B) Th   e expression of transfected gene was monitored with fl  uorescence.936 MIN KOOK KANG ET AL.
that regulate cell proliferation reside within the nu-
cleolus. The exact role of NIR, a nucleolar protein 
(Fig. 2), remains unclear. NIR expression was higher 
in cancer cell lines than in non-cancer cell lines (Fig. 
4B) and the level of NIR fluctuated during the cell 
cycle progression (Fig. 4A). Furthermore, the rate of 
cell proliferation increased following overexpression 
of NIR (Fig. 5). The ability of NIR to regulate cell 
proliferation may be dependent on its interaction 
with p53 and p63, which regulate cell cycle arrest 
and apoptosis. However, is it also possible that the 
effects of NIR upon cell proliferation are independ-
ent of p53 and p63. Further study is required to de-
termine whether NIR modulates cell proliferation 
by binding another protein(s). 
Since  NIR  has  a  putative  nuclear  localization 
signal, we decided to study the localization of NIR 
protein  using  two  approaches.  First,  anti-NIR  an-
tibodies were used to determine the localization of 
endogenous NIR protein. Second, the localization of 
overexpressed GFP-NIR was observed. In both cases, 
NIR accumulated in the nucleolus and a small por-
tion of the protein was detected in the nucleoplasm 
(Fig 2), in agreement with a previous study (Heyne 
et al., 2010). However, this result is inconsistent with 
other studies that reported that, according to immu-
nocytochemical  analyses,  NIR  is  mainly  localized 
in the nucleoplasm (Hublitz et al., 2005, Wu et al., 
2011). It is possible that specific signals or conditions 
stimulate translocation of NIR from the nucleolus to 
the nucleoplasm. Many nucleolar proteins can be re-
distributed to other locations. B23 shuttles between 
the cytoplasm and the nucleolus by binding other 
nucleolar proteins (Ma et al., 2006, Yung et al., 1991). 
C23 is located in the nucleolus, nucleoplasm and at 
the cell surface (Masiuk et al., 2007, Xue et al., 1993). 
Because NIR, C23 and B23 are all predominantly lo-
calized in the nucleolus and shuttle to another loca-
tion, it is possible that NIR interacts with these pro-
teins. Indeed, C23 and B23 interact each other (Li et 
al., 1996). 
The calculated molecular weight of NIR is about 
85kD; however, NIR was detected around 95kD in 
the SDS-PAGE gel (Fig 1). In addition, NIR migrated 
faster in the soluble fraction (nucleoplasm and cy-
toplasm) than in the insoluble fraction (nucleolus) 
(Fig.  1A).  This  suggests  that  a  post-translational 
modification  of  NIR,  such  as  dephosphorylation, 
deacetylation, desumoylation or deubiquitination, is 
responsible for its redistribution from the nucleolus 
to the nucleoplasm. Aurora B kinase interacts with 
the complex of NIR and p53, even though the kinase 
phosphorylates p53 not NIR (Wu et al., 2011). It is 
possible that another kinase was responsible for NIR 
phosphorylation. In fact, phosphor-amino acid anal-
ysis indicated that a serine residue(s) of NIR is phos-
phorylated  in  our  recent  study  (data  not  shown). 
Further study is required to characterize this modi-
fication, which may provide insight into the func-
tion of NIR. Cellular proliferation is controlled by a 
complex network of signaling molecules and further 
investigation is warranted to determine how this sig-
naling controls the function of NIR. 
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